1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Great Pox in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barquinero, J; Khamashta, M; Ordi-Ros, J; Perez-Peman, P; Selva, A; Vilardell, M | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Great Pox
| Article | Year |
|---|---|
Antibodies against platelet-activating factor in patients with antiphospholipid antibodies.
Topics: Antibodies, Antiphospholipid; Antibody Specificity; Antiphospholipid Syndrome; Autoantibodies; Humans; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Platelet Activating Factor; Syphilis | 1994 |